These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 1326287)

  • 1. Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.
    Pucci F; Bogaerts P; Rooman M
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33265982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors.
    Nelveg-Kristensen KE; Bie P; Ferrero L; Bjerre D; Bruun NE; Egfjord M; Rasmussen HB; Hansen PR;
    PLoS One; 2016; 11(9):e0163341. PubMed ID: 27662362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of cell surface expression of human ACE leads to perinatal death.
    Michaud A; Acharya KR; Masuyer G; Quenech'du N; Gribouval O; Morinière V; Gubler MC; Corvol P
    Hum Mol Genet; 2014 Mar; 23(6):1479-91. PubMed ID: 24163131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension.
    Gironacci MM; Brosnihan KB; Ferrario CM; Gorzalczany S; Verrilli MA; Pascual M; Taira C; Peña C
    Peptides; 2007 Aug; 28(8):1580-5. PubMed ID: 17646033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-adherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assays.
    Struthers AD; Anderson G; MacFadyen RJ; Fraser C; MacDonald TM
    Heart; 1999 Nov; 82(5):584-8. PubMed ID: 10525514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.
    Nowack R; Fliser D; Richter J; Horne C; Mutschler E; Ritz E
    Clin Investig; 1993 Aug; 71(8):622-7. PubMed ID: 8219659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
    Pellacani A; Brunner HR; Nussberger J
    Clin Sci (Lond); 1994 Nov; 87(5):567-74. PubMed ID: 7874846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
    Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T
    Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
    Nussberger J; Juillerat L; Perret F; Waeber B; Bellet M; Brunner J; Ménard J
    Am Heart J; 1989 Mar; 117(3):717-22. PubMed ID: 2537557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of angiotensin II generation during converting enzyme inhibition.
    Juillerat L; Nussberger J; Ménard J; Mooser V; Christen Y; Waeber B; Graf P; Brunner HR
    Hypertension; 1990 Nov; 16(5):564-72. PubMed ID: 2172161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    Hypertension; 1986 Jun; 8(6):476-82. PubMed ID: 3011664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
    Nussberger J; Brunner D; Keller I; Brunner HR
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):393-8. PubMed ID: 1326287
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.